Advanced Health Intelligence
Kevin Baum has a diverse work experience in various roles and companies. Kevin is currently the Chief Product Officer at Advanced Health Intelligence since November 2022. Before that, they were a Program Manager at Advanced Human Imaging, where they helped application developers utilize human measurement SDKs and services. Prior to that, they served as the Chief Executive Officer of Devtech Digital and was also the Founder of New Normal Digital. Kevin has also held positions such as Managing Director at TikForce Ltd and CEO at TikForce Operations. Additionally, they have experience as a CEO and Managing Director at NetSavii, where they built online businesses and provided functional online solutions. Kevin has also worked as a CEO at TikForce Pty Ltd and held roles like Business Development Director at onsavii and Ready Flowers Limited.
Kevin Baum attended Carine High School from 1974 to 1979, where they obtained a Leaving Certificate with a focus on subjects such as Physics, Chemistry, Maths, Literature, Art, and English. Kevin then studied Industrial Design at Curtin University from 1978 to 1981, but their degree remains incomplete. In terms of additional certifications, Kevin obtained certifications in "Learning Adobe XD" from Lynda.com in 2017 and "Draw Better and Faster with Illustrator CC" from lynda.com in 2014.
Advanced Health Intelligence
Advanced Health Intelligence (NASDAQ:AHI, ASX:AHI) is committed to becoming a global leader in digital health. We harness proprietary technology and innovative processes to redefine health screening. Leveraging the ubiquity and convenience of smartphones, AHI aims to deliver a comprehensive suite of assessment tools globally to healthcare providers, caregivers, insurers, and governments. Our mission is to enhance healthcare delivery and support the early detection and prevention of chronic diseases. Our patented technology has evolved into a robust suite of solutions that symbolize the future of digitized healthcare. These include: • Body dimension and composition assessments, enabling the identification of obesity-related comorbidities such as diabetes. • Blood biomarker prediction, inclusive of HbA1C, HDL, LDL, and 10-year mortality risk. • Transdermal Optical Imaging, providing vital signs and cardiovascular disease risk estimates. • On-device dermatological skin identification, capable of recognizing 588 skin conditions across 133 categories, including melanoma. • Assisting partners in delivering personalized therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy. Our world-class team—comprising machine learning and AI experts, computer vision specialists, and medically trained data scientists—ensures that AHI remains at the cutting edge of health-tech innovation. We aspire to create a transformative impact at scale, driving forward a new era in digital healthcare. Our biometrically derived triage solution, accessible via smartphone, enables our partners to identify and manage health risks at a population scale. Through technology, AHI contributes to a more efficient, effective, and inclusive global healthcare system. We stand ready to guide healthcare providers, caregivers, insurers, and governments in triaging individuals into the most suitable care pathways.